Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
🔮 Better than the Oracle? Our Fair Value found this +42% bagger 5 months before Buffett bought it Read More
Close

Bloom Health Partners Inc (BLMH)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
Bloom Health Partners historical data, for real-time data please try another search
0.08 0.00    0.00%
10/11 - Closed. Currency in CAD ( Disclaimer )
Type:  Equity
Market:  Canada
  • Volume: 0
  • Bid/Ask: 0.08 / 0.08
  • Day's Range: 0.08 - 0.09
Bloom Health Partners 0.08 0.00 0.00%

BLMH Ratios

 
Assess the performance of Bloom Health Partners (BLMH). This table contains core financial ratios such as Price-to-Earnings (P/E ratio), Return-On-Investment (ROI), Earnings per share (EPS), Dividend yield and others based on Bloom Health Partners Inc's latest financial reports. Compare the performance metrics of Bloom Health Partners (BLMH) against the industry averages.
Advanced Ratios
Name Company Industry
   
P/E Ratio TTM - -18.9
Price to Sales TTM - 9.62
Price to Cash Flow MRQ - -226.56
Price to Free Cash Flow TTM - -17.58
Price to Book MRQ - 1.01
Price to Tangible Book MRQ - -0.9
   
Profitability: TTM vs 5 Year Average Margins
 TTM (%)
 5 Year Avg. (%)
Gross margin TTM - 56.47
Gross Margin 5YA - 52.29
Operating margin TTM - -144.69
Operating margin 5YA - -131.6
Pretax margin TTM - -156.47
Pretax margin 5YA - -162.96
Net Profit margin TTM - -158.02
Net Profit margin 5YA - -522.71
   
Revenue/Share TTM - 8.89
Basic EPS ANN - -0.64
Diluted EPS ANN - -0.64
Book Value/Share MRQ - 14.7
Tangible Book Value/Share MRQ - -2.7
Cash/Share MRQ - 0.77
Cash Flow/Share TTM - -0.05
   
Management Effectiveness: TTM vs 5 Year Average Margins
 TTM (%)
 5 Year Avg. (%)
Return on Equity TTM - -18.32
Return on Equity 5YA - -44.87
Return on Assets TTM - -15.27
Return on Assets 5YA - -18.69
Return on Investment TTM - -4.51
Return on Investment 5YA - -6.94
   
EPS(MRQ) vs Qtr. 1 Yr. Ago MRQ - -3,938.79
EPS(TTM) vs TTM 1 Yr. Ago TTM - -3,295.56
5 Year EPS Growth 5YA - -
Sales (MRQ) vs Qtr. 1 Yr. Ago MRQ - 27.65
Sales (TTM) vs TTM 1 Yr. Ago TTM - 11.57
5 Year Sales Growth 5YA - 4.92
5 Year Capital Spending Growth 5YA - 11.02
   
Quick Ratio MRQ - 1.31
Current Ratio MRQ - 2.41
LT Debt to Equity MRQ - 51.22
Total Debt to Equity MRQ - 38.11
Efficiency    
Asset Turnover TTM - 0.33
Inventory Turnover TTM - 2.42
Revenue/Employee TTM - 243.15K
Net Income/Employee TTM - -23.73K
Receivable Turnover TTM - 5.15
   
Dividend Yield ANN - -
Dividend Yield 5 Year Avg. 5YA - -
Dividend Growth Rate ANN - -
Payout Ratio TTM - -
TTM = Trailing Twelve Months  5YA = 5-Year Average  MRQ = Most Recent Quarter
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced valuation and financial ratios for in-depth analysis of company financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

BLMH Comments

Write your thoughts about Bloom Health Partners Inc
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Mike Powell
Mike Powell Oct 25, 2022 12:06PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Bloom reached their goal of $25M in revenue within the first 9 months of F’2022 in their Q3 financial results. Earlier this year their revenue guidance for the full year was $25M so they have reached this goal following the reported $8.4M revenue in Q3 alone. Their growth trajectory isn’t stopping with new locations opening to serve the greater Chicago area and Hawaii. Video on YouTube titled:Bloom Health $BLMH Hits $25M In Revenue And Full Year Guidance In Just 9 Months
Reply
0 0
Report
Mike Powell
Mike Powell Sep 02, 2022 2:25PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Bloom releases positive Q3 results reporting a profitable quarter bringing in C$5.9M in Q3 for a YTD total of $24.9M. Also announcing extension of the contract with State of Texas K-12 schools for an additional year. BLMH CEO Andrew Morton in new interview discussing these results and the contract extension. Video on YouTube titled: Bloom Health Partners releases Q3 financials seeing profitable quarter
Reply
0 0
Report
Mike Powell
Mike Powell Aug 17, 2022 1:22PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
The technical picture for Bloom Health is bullish - at these prices it’s a good time to add positions while waiting on some news, especially comparing to others in this space they are incredibly undervalued with huge growth opportunities with F500s especially when considering the context of addressing critical staffing shortages faced by many industries.
Reply
0 0
Report
Mike Powell
Mike Powell Jul 26, 2022 12:33PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
BLMH announces closing of its second tranche of private placement raising a combined aggregate gross total of $1,58M. This successful raise follows the company’s announced profitable Q2 generating $11.1M in revenue with an EBITDA of $2.1M. They are fully cashed up and with another news release or new announced client, can see significant traction and stronger volumes. Seriously undervalued.
Reply
0 0
Report
Mike Powell
Mike Powell Jun 08, 2022 11:46AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Following Bloom Health Partners’ strong Q2 results that reported doubled Quarter over Quarter revenues, BLMH has announced the launch of a non-brokered private placement offering units at $0.2 for gross proceeds of up to $2M.Bloom Health Partners reports their Q2 F’22 results with revenues that essentially double their Quarter over Quarter revenues - $11.1M for Q2 which brings their total YTD revenues to $16.9M. Testament to strong growth trends and high uptake following the company’s Bloom Shield health-tech platform launch.
Reply
0 0
Report
Mike Powell
Mike Powell Jun 02, 2022 2:41PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Bloom Health Partners reports their Q2 F’22 results with revenues that nearly double their Quarter over Quarter revenues - $11.1M for Q2 bringing their total YTD revenues of $16.9M.
Reply
0 0
Report
Jeremy Lin
Jeremy Lin Jun 02, 2022 2:03PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
They just beat their entire 2021 year’s revenue ($9.8M) with a similar EBITDA. As they continue adding to the management team and securing new deals, the outlook looks solid here. High growth, profitable, and in a non-speculative industry with only an $8.6M market cap. I'll be keeping a close eye on these guys.
Reply
0 0
Report
Jeremy Lin
Jeremy Lin Jun 01, 2022 2:26PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Considering that their revenue targets were $25M-$28M for the 2022 fiscal year, and they’ve already hit $16.9M halfway through (and are continuing to grow quarter after quarter), there's a lot of upside at these levels. 92.1% growth to $11.1M in revenue with a positive EBITDA from a single quarter, it's a no-brainer to say this is undervalued.
Reply
0 0
Report
Troy Barnes
Troy Barnes Apr 21, 2022 4:40PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
$BLMH offers a scalable system for businesses and organizations that helps engage employees and creates strategies to manage health and safety.They are a global platform for healthcare security, diagnostic testing and occupational health-tech. Think COVID testing. This is a stock for current times and beyond. Share price at a low $0.23. Could be the perfect time with an inevitable market resurgence.CSE: BLMH, OTCQB: BLMHF, FRA: D84
Reply
0 0
Report
Mike Powell
Mike Powell Feb 18, 2022 1:05PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Bloom Health Partners announced this week the launch of their new operational health-tech cloud platform, “Bloom Shield,” managing employee health for workplaces and large organizations. The platform will provide immediate and long-term health requirements managing employee health and risk requirements in the workplace, empowering employers to make data-driven decisions about their operations.
Reply
0 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email